Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Dale Broadrick10% Owner | BioRestorative TherapiesBRTX | Open-market sale | 24/10/28 | 24/11/05 | 1,112 sh | $1.58 | $1,756.96 | −0.2% |
BioRestorative TherapiesBRTX | Open-market buy | 24/04/08–24/04/09 | 24/04/10 | 8,308 sh3 trades | $1.23avg. | $10,229.32 | +5.6% | |
BioRestorative TherapiesBRTX | Open-market buy | 24/02/08–24/02/09 | 24/02/12 | 160,000 sh2 trades | $1.29avg. | $206,022.87 | +50.3% | |
BioRestorative TherapiesBRTX | Open-market buy | 24/02/07–24/02/08 | 24/02/09 | 120,000 sh2 trades | $1.35avg. | $162,254.96 | +36.7% | |
Dale Broadrick10% Owner | BioRestorative TherapiesBRTX | Open-market sale | 23/12/01 | 23/12/05 | 250 sh | $1.88 | $470 | −0.1% |
Dale Broadrick10% Owner | BioRestorative TherapiesBRTX | Open-market sale | 23/11/27 | 23/12/01 | 278 sh | $1.89 | $525.42 | −0.1% |
BioRestorative TherapiesBRTX | Open-market buy | 23/09/14–23/09/15 | 23/09/18 | 20,000 sh2 trades | $1.60avg. | $32,000 | +6.5% | |
Lance AlstodtPresident, CEO, COB | BioRestorative TherapiesBRTX | Open-market buy | 23/09/15 | 23/09/18 | 2,200 sh | $1.70 | $3,740 | +1.2% |
BioRestorative TherapiesBRTX | Open-market buy | 23/07/28–23/09/07 | 23/09/14 | 2,500 sh3 trades | $2.07avg. | $5,165 | No record | |
Lance AlstodtPresident, CEO, COB | BioRestorative TherapiesBRTX | Open-market buy | 23/09/13 | 23/09/13 | 800 sh | $1.53 | $1,224 | +0.4% |
Lance AlstodtPresident, CEO, COB | BioRestorative TherapiesBRTX | Open-market buy | 23/09/06 | 23/09/06 | 2,887 sh | $1.96 | $5,658.52 | +1.6% |
Francisco SilvaVP of Research and Development | BioRestorative TherapiesBRTX | Open-market buy | 23/08/31 | 23/08/31 | 4,954 sh | $2.22 | $10,997.88 | +3.1% |
Dale Broadrick10% Owner | BioRestorative TherapiesBRTX | Open-market buy | 23/07/27 | 23/07/28 | 1,000 sh | $2.80 | $2,800 | +0.3% |
Lance AlstodtPresident, CEO, COB | BioRestorative TherapiesBRTX | Open-market buy | 23/07/25 | 23/07/25 | 4,200 sh | $2.44 | $10,248 | +2.3% |
Francisco SilvaVP of Research and Development | BioRestorative TherapiesBRTX | Open-market buy | 23/03/31 | 23/04/04 | 747 sh | $3.56 | $2,659.32 | +0.5% |
BioRestorative TherapiesBRTX | Open-market buy | 22/11/30–23/02/22 | 23/03/03 | 6,200 sh4 trades | $2.86avg. | $17,705 | +2.1% | |
Lance AlstodtPresident, CEO, COB | BioRestorative TherapiesBRTX | Open-market buy | 23/02/01 | 23/02/02 | 400 sh | $3.10 | $1,240 | +0.2% |
Lance AlstodtPresident, CEO, COB | BioRestorative TherapiesBRTX | Open-market buy | 23/01/27 | 23/01/30 | 200 sh | $3.01 | $602 | +0.1% |
BioRestorative TherapiesBRTX | Open-market buy | 23/01/20 | 23/01/24 | 200 sh2 trades | $3.14avg. | $627 | +0.1% | |
BioRestorative TherapiesBRTX | Open-market buy | 23/01/18 | 23/01/20 | 400 sh3 trades | $3.11avg. | $1,245 | +0.2% |